These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12500906)

  • 1. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(47):1065-7. PubMed ID: 12500906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
    JAMA; 2003 Jan; 289(1):36-7. PubMed ID: 12515265
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver transplantation and the use of KAVA: Case report.
    Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR
    Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of kava hepatotoxicity and the FDA consumer advisory.
    Teschke R; Schulze J
    JAMA; 2010 Nov; 304(19):2174-5. PubMed ID: 21081732
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis induced by Kava (Piper methysticum rhizoma).
    Stickel F; Baumüller HM; Seitz K; Vasilakis D; Seitz G; Seitz HK; Schuppan D
    J Hepatol; 2003 Jul; 39(1):62-7. PubMed ID: 12821045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava hepatotoxicity--a clinical review.
    Teschke R
    Ann Hepatol; 2010; 9(3):251-65. PubMed ID: 20720265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hepatitis induced by kava kava.
    Humberston CL; Akhtar J; Krenzelok EP
    J Toxicol Clin Toxicol; 2003; 41(2):109-13. PubMed ID: 12733846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.
    Teschke R; Genthner A; Wolff A
    J Ethnopharmacol; 2009 Jun; 123(3):378-84. PubMed ID: 19501269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another FDA warning: Kava supplements.
    Parkman CA
    Case Manager; 2002; 13(4):26-8. PubMed ID: 12131903
    [No Abstract]   [Full Text] [Related]  

  • 10. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.
    Klontz KC; DeBeck HJ; LeBlanc P; Mogen KM; Wolpert BJ; Sabo JL; Salter M; Seelman SL; Lance SE; Monahan C; Steigman DS; Gensheimer K
    Public Health Rep; 2015; 130(5):526-32. PubMed ID: 26327730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava concerns. FDA, Botanical Council raises safety concerns.
    AWHONN Lifelines; 2002; 6(1):13-5. PubMed ID: 11971236
    [No Abstract]   [Full Text] [Related]  

  • 13. Kava extract, an herbal alternative for anxiety relief, potentiates acetaminophen-induced cytotoxicity in rat hepatic cells.
    Yang X; Salminen WF
    Phytomedicine; 2011 May; 18(7):592-600. PubMed ID: 21397479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava hepatotoxicity: a European view.
    Teschke R; Schwarzenboeck A; Akinci A
    N Z Med J; 2008 Oct; 121(1283):90-8. PubMed ID: 18841189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kava: a supplement to avoid.
    Consum Rep; 2003 Mar; 68(3):8. PubMed ID: 12599340
    [No Abstract]   [Full Text] [Related]  

  • 16. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.
    Estes JD; Stolpman D; Olyaei A; Corless CL; Ham JM; Schwartz JM; Orloff SL
    Arch Surg; 2003 Aug; 138(8):852-8. PubMed ID: 12912743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kava kava: examining new reports of toxicity.
    Clouatre DL
    Toxicol Lett; 2004 Apr; 150(1):85-96. PubMed ID: 15068826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kava: herbal panacea or liver poison?
    Moulds RF; Malani J
    Med J Aust; 2003 May; 178(9):451-3. PubMed ID: 12720513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava hepatotoxicity: regulatory data selection and causality assessment.
    Teschke R; Wolff A
    Dig Liver Dis; 2009 Dec; 41(12):891-901. PubMed ID: 19477698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ethanol in kava hepatotoxicity.
    Li XZ; Ramzan I
    Phytother Res; 2010 Apr; 24(4):475-80. PubMed ID: 19943335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.